Abbott Laboratories (ABT) Change in Accured Expenses (2009)

Abbott Laboratories (ABT) reported Change in Accured Expenses of $422.4 million for Q4 2009.

Abbott Laboratories (ABT) Change in Accured Expenses (2009) Analysis & Trends

Abbott Laboratories (ABT) has 1 years of Change in Accured Expenses data on file, last reported at $422.4 million in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-654.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	123.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-512.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-347.10 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	145.10 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	21.07 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-250.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Steris	20.59 Bn	20.16 Bn	697.10 Mn	74.30 Mn

Download Data

Date	Value
Dec 31, 2009	422.42 Mn
Dec 31, 2009	422.42 Mn